United States

GE’s underlying Organizations in Strong Position, says CEO Jeff Immelt

GE’s underlying Organizations in Strong Position, says CEO Jeff Immelt

General Electric faced a $13 billion loss in the initial quarter as it begins the process of selling of GE Capital. But CEO Jeff Immelt said on Friday that despite that fact, the position of the industrial organization remains strong and ready for development.

“In between investigation and improvement, investment in plant gear and info technologies, and the prospective for industrial (acquisitions), we'll invest $10 billion to $15 billion each and every year in our industrial growth”, stated Immelt.

Fannie Mae and Freddie Mac will hold guarantee fees for mortgages at existing levels

Fannie Mae and Freddie Mac will hold guarantee fees for mortgages at existing levels

The US housing finance firms have been asked to improve their structure for guarantee fees. The regulator has directed Fannie Mae and Freddie Mac to take the steps. However, it said that the changes would be 'revenue neutral'.

According to the Federal Housing Finance Agency (FHFA), Fannie and Freddie will cut guarantee fees for some borrowers and increase them for others. Predictably, the regulator is removing a 25-basis-point adverse market fee, which the companies forced on all new borrowers in 2008, when housing prices fell rapidly.

Surgeon General Vivek Murthy teams up with Elmo to promote vaccinations

United States Dr. Vivek H. Murthy

Surgeon General of the United States Dr. Vivek H. Murthy and the Department of Health and Human Services have joined forces with Elmo, Muppet character on the children's television show Sesame Street, to help children in the United States directly receive vaccinations.

On Friday, Murthy revealed a 30-second public service announcement with Elmo in a blog post published on the Department of Health and Human Services website. In the YouTube video, Murthy and the Muppet character tell children about the importance of getting their vaccinations on time.

Category: 

Panera Bread approves $500 Million in New Debt to Fund Buyback Program

Panera Bread approves $500 Million in New Debt to Fund Buyback Program

Panera Bread management has permitted $500 million in new debt with a purpose to fund a buyback program after engaging in a constructive dialogue with activist hedge fund Luxor Capital Group.

When the company made announcement that it has increased the buyback program to $750 million, the stock jumped as investors picked up the stock. The company has plans to buy back $500 million in shares with cash on hand, cash flow, and the new debt over the next year.

UnitedHealth Group delivers its best quarter in years

UnitedHealth Group delivers its best quarter in years

On Thursday, UnitedHealth Group delivered its best quarterly results in years as it received benefits from new ObamaCare customers. It also raised its full-year 2015 sales and earnings guidance.

The nation's No. 1 health insurer has logged first-quarter earnings of $1.46 per share, up 33% vs. compared to year earlier. The net profit was much higher than analyst estimates for $1.35. The company registered 13% gain in revenue to $35.76 billion, topping views for $34.6 billion.

FDA approves Sandoz’s Glatopa to Treat Multiple Sclerosis

FDA approves Sandoz’s Glatopa to Treat Multiple Sclerosis

Sandoz, a Novartis company, announced that the United States Food and Drug Administration (FDA) has approved its Glatopa, which the first generic alternative version for Teva Pharmaceutical's multiple sclerosis treatment Copaxone. According to reports, Glatopa has been approved as treatment for multiple sclerosis.

Category: 

Success Kid helps Raise Funds for Father's Kidney Transplant

Success Kid helps Raise Funds for Father's Kidney Transplant

A kid has raised more than $75,000 to help his father get a kidney transplant. The kid is highly recognized on the internet. The so-called Success Kid made plea with his family last week to provide funding for his father Justin, 39, to get a kidney transplant.

Category: 

FDA gives nod to Amgen’s Heart-Failure Treatment Corlanor

FDA gives nod to Amgen’s Heart-Failure Treatment Corlanor

Amgen's heart-failure treatment Corlanor has got a green signal from the US Food and Drug Administration. The drug was designated for priority review in August.

The drug is believed to have high efficacy of regulating heart rate and reducing the risk of hospitalization for worsening heart failure. The drug is meant for patients with stable, chronic heart failure caused by a poorly-contracting lower-left part of the heart.

Category: 

A device could help reduce pain caused by shot

A device could help reduce pain caused by shot

Each year, many Americans go to a doctor or a local pharmacy to get at least one shot. The number increases in case of growing children as they are vaccinated for many new and very old illnesses. Rice University researchers are making efforts to make the shots less painful.

A team of freshman engineering students at the school have created a device, which causes a quick chemical reaction to cool a patient's skin before receiving a shot. It has been proved that the device can numb a patient's skin within 60 seconds.

Category: 

Pages

Zircon - This is a contributing Drupal Theme
Design by WeebPal.